Advertisement

Effect of Dexamethasone on Myocardial Injury After Total Knee Arthroplasty: A Substudy of the Randomized Clinical DEX-2-TKA Trial

Published:October 14, 2022DOI:https://doi.org/10.1016/j.amjmed.2022.09.031

      Abstract

      Background

      Myocardial injury after noncardiac surgery (MINS) carries a high postoperative mortality. In this preplanned, subgroup analysis of the randomized DEX-2-TKA Trial, we investigated the effect of dexamethasone versus placebo on the concentration of cardiac troponin I and T (TnI and TnT) on the first postoperative morning after total knee arthroplasty. In addition, frequency of MINS, myocardial infarction, and major adverse cardiovascular events where evaluated.

      Methods

      We included 290 patients who received either 24 mg of dexamethasone intravenously (given perioperatively) or placebo. Blood samples were analyzed as either TnI or T depending on trial site.

      Results

      A total of 236 samples were eligible for analysis of TnI and 38 samples for TnT on the first postoperative morning. The median (IQR) TnI concentration was 4.6 ng/L (0-7.2 ng/L) in the dexamethasone group and 4.5ng/l (0-7.0 ng/L) in the placebo group (P = .96) on the first postoperative morning. The median TnT was 9 ng/L (6-11 ng/L) in the dexamethasone group and 8 ng/L (5-10 ng/L) in the placebo group (P = .68). The frequencies of MINS, myocardial infarction, and major adverse cardiovascular events were similar in the compared groups, but these analyses were underpowered.

      Conclusion

      We found no effect of dexamethasone on postoperative concentration of troponin I or T on the first postoperative morning after total knee arthroplasty.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lee TH
        • Thomas EJ
        • Ludwig LE
        • et al.
        Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery.
        Am J Cardiol. 1996; 77: 1031-1036https://doi.org/10.1016/S0002-9149(96)00126-9
        • Gualandro DM
        • Puelacher C
        • LuratiBuse G
        • et al.
        Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery.
        Am Heart J. 2018; 203: 67-73https://doi.org/10.1016/j.ahj.2018.06.012
        • MiccichÈ V
        • Baldi C
        • De Robertis E
        • Piazza O
        Myocardial injury after non-cardiac surgery: A perioperative affair?.
        Minerva Anestesiol. 2018; 84: 1209-1218https://doi.org/10.23736/s0375-9393.18.12537-5
        • Roshanov PS
        • Sessler DI
        • Chow CK
        • et al.
        Predicting myocardial injury and other cardiac complications after elective noncardiac surgery with the revised cardiac risk index: the VISION Study.
        Can J Cardiol. 2021; 37: 1215-1224https://doi.org/10.1016/j.cjca.2021.03.015
        • Devereaux PJ
        • Chan MT
        • Alonso-Coello P
        • et al.
        Association between postoperative troponin troponin levels and 30-day mortality among patients undergoing noncardiac surgery.
        J Am Med Assoc. 2012; 307: 2295-2304
        • Ekeloef S
        • Alamili M
        • Devereaux PJ
        • Gögenur I.
        Troponin elevations after non-cardiac, non-vascular surgery are predictive of major adverse cardiac events and mortality: a systematic review and meta-analysis.
        Br J Anaesth. 2016; 117: 559-568https://doi.org/10.1093/bja/aew321
        • Szczeklik W
        • Fronczek J.
        Myocardial injury after noncardiac surgery - an update.
        Curr Opin Anaesthesiol. 2021; 34: 381-386https://doi.org/10.1097/ACO.0000000000000981
        • Welsh P
        • Preiss D
        • Hayward C
        • et al.
        Cardiac troponin T and troponin I in the general population: comparing and contrasting their genetic determinants and associations with outcomes.
        Circulation. 2019; 139: 2754-2764https://doi.org/10.1161/CIRCULATIONAHA.118.038529
        • Thorsteinsdottir I
        • Aspelund T
        • Gudmundsson E
        • et al.
        High-sensitivity cardiac troponin I is a strong predictor of cardiovascular events and mortality in the AGES-Reykjavik community-based cohort of older individuals.
        Clin Chem. 2016; 62: 623-630https://doi.org/10.1373/clinchem.2015.250811
        • Biener M
        • Giannitsis E
        • Hogrefe K
        • et al.
        Prognostic value of changes in high-sensitivity cardiac troponin T beyond biological variation in stable outpatients with cardiovascular disease: a validation study.
        Clin Res Cardiol. 2022; 111: 333-342https://doi.org/10.1007/s00392-021-01952-6
        • Khan J
        • Alonso-Coello P
        • Devereaux PJ.
        Myocardial injury after noncardiac surgery.
        Curr Opin Cardiol. 2014; 29: 307-311https://doi.org/10.1097/HCO.0000000000000069
        • Devereaux PJ
        • Sessler DI.
        Cardiac complications in patients undergoing major noncardiac surgery.
        N Engl J Med. 2015; 373: 2258-2269https://doi.org/10.1056/NEJMra1502824
        • Hu W
        • Chen Y
        • Zhao K
        • et al.
        Association of perioperative myocardial injury with 30-day and long-term mortality in older adult patients undergoing orthopedic surgery in China.
        Med Sci Monit. 2021; 27: 1-11https://doi.org/10.12659/MSM.932036
        • Devereaux PJ
        • Lamy A
        • Chan MTV
        • et al.
        High-sensitivity troponin I after cardiac surgery and 30-day mortality.
        N Engl J Med. 2022; 386: 827-836https://doi.org/10.1056/nejmoa2000803
        • Devereaux PJ
        • Duceppe E
        • Guyatt G
        • et al.
        Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial.
        Lancet. 2018; 391: 2325-2334https://doi.org/10.1016/S0140-6736(18)30832-8
        • Ekeloef S
        • Homilius M
        • Stilling M
        • et al.
        The effect of remote ischaemic preconditioning on myocardial injury in emergency hip fracture surgery (PIXIE trial): phase II randomised clinical trial.
        BMJ. 2019; 367: I6395https://doi.org/10.1136/bmj.l6395
        • Lomivorotov V
        • Kornilov I
        • Boboshko V
        • et al.
        Effect of intraoperative dexamethasone on major complications and mortality among infants undergoing cardiac surgery: the DECISION randomized clinical trial.
        JAMA. 2020; 323: 2485-2492https://doi.org/10.1001/jama.2020.8133
        • Asehnoune K
        • Le Moal C
        • Lebuffe G
        • et al.
        Effect of dexamethasone on complications or all cause mortality after major non-cardiac surgery: multicentre, double blind, randomised controlled trial.
        BMJ. 2021; 373: 1-12https://doi.org/10.1136/bmj.n1162
        • Ferreira SH
        • Cunha FQ
        • Lorenzetti BB
        • et al.
        Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone.
        Br J Pharmacol. 1997; 121: 883-888https://doi.org/10.1038/sj.bjp.0701211
        • Lunn TH
        • Kristensen BB
        • Andersen L
        • et al.
        Effect of high-dose preoperative methylprednisolone on pain and recovery after total knee arthroplasty: a randomized, placebo-controlled trial.
        Br J Anaesth. 2011; 106: 230-238https://doi.org/10.1093/bja/aeq333
        • Ganio EA
        • Stanley N
        • Lindberg-Larsen V
        • et al.
        Preferential inhibition of adaptive immune system dynamics by glucocorticoids in patients after acute surgical trauma.
        Nat Commun. 2020; 11: 1-12https://doi.org/10.1038/s41467-020-17565-y
      1. Meng J, Li L. The efficiency and safety of dexamethasone for pain control in total joint arthroplasty. Medicine (Baltimore). 2017;96(24):e7126. https://doi.org/10.1097/md.0000000000007126.

        • De La Motte L
        • Kehlet H
        • Vogt K
        • et al.
        Preoperative methylprednisolone enhances recovery after endovascular aortic repair: A randomized, double-blind, placebo-controlled clinical trial.
        Ann Surg. 2014; 260: 540-549https://doi.org/10.1097/SLA.0000000000000895
        • Yue C
        • Wei R
        • Liu Y.
        Perioperative systemic steroid for rapid recovery in total knee and hip arthroplasty: a systematic review and meta-analysis of randomized trials.
        J Orthop Surg Res. 2017; 12: 100https://doi.org/10.1186/s13018-017-0601-4
        • Gasbjerg KS
        • Hägi-Pedersen D
        • Lunn TH
        • et al.
        Effect of dexamethasone as an analgesic adjuvant to multimodal pain treatment after total knee arthroplasty: randomised clinical trial.
        BMJ. 2022; 376: 1-11https://doi.org/10.1136/bmj-2021-067325
        • Hadoke PWF
        • Iqbal J
        • Walker BR.
        Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.
        Br J Pharmacol. 2009; 156: 689-712https://doi.org/10.1111/j.1476-5381.2008.00047.x
        • Ruetzler K
        • Smilowitz NR
        • Berger JS
        • et al.
        Diagnosis and management of patients with myocardial injury after noncardiac surgery: a scientific statement from the American Heart Association.
        Circulation. 2021; 144: e287-e305https://doi.org/10.1161/CIR.0000000000001024
        • Gasbjerg KS
        • Hägi-Pedersen D
        • Lunn TH
        • et al.
        DEX-2-TKA—DEXamethasone twice for pain treatment after total knee arthroplasty: a protocol for a randomized, blinded, three-group multicentre clinical trial.
        Acta Anaesthesiol Scand. 2020; 64: 267-275https://doi.org/10.1111/aas.13481
        • Gasbjerg KS
        • Hägi-Pedersen D
        • Lunn TH
        • et al.
        DEX-2-TKA - DEXamethasone twice for pain treatment after total knee arthroplasty: detailed statistical analysis plan for a randomized, blinded, three-group multicentre clinical trial.
        Acta Anaesthesiol Scand. 2020; 64: 839-846https://doi.org/10.1111/aas.13560
        • Devereaux PJ
        • Biccard BM
        • Sigamani A
        • et al.
        Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery.
        JAMA. 2017; 317: 1642-1651https://doi.org/10.1001/jama.2017.4360
        • Duceppe E
        • Parlow J
        • MacDonald P
        • et al.
        Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery.
        Can J Cardiol. 2017; 33: 17-32https://doi.org/10.1016/j.cjca.2016.09.008
        • Xu B
        • Strom J
        • Chen QM.
        Dexamethasone induces transcriptional activation of Bcl-xL gene and inhibits cardiac injury by myocardial ischemia.
        Eur J Pharmacol. 2011; 668: 194-200https://doi.org/10.1016/j.ejphar.2011.06.019
        • Liu B
        • Zhang TN
        • Knight JK
        • Goodwin JE.
        The glucocorticoid receptor in cardiovascular health and disease.
        Cells. 2019; 8: 1-21https://doi.org/10.3390/cells8101227
        • Rossaint J
        • Zarbock A.
        Perioperative inflammation and its modulation by anesthetics.
        Anesth Analg. 2018; 126: 1058-1067https://doi.org/10.1213/ANE.0000000000002484
        • Rossaint J
        • Zarbock A.
        Anesthesia-induced immune modulation.
        Curr Opin Anaesthesiol. 2019; 32: 799-805https://doi.org/10.1097/ACO.0000000000000790